CLMP, GNG12, LOX, LY6E, MYL12B, and SOX4 were reported for the first time as prognostic signature genes for PAAD, and the mechanisms of how they regulate PAAD occurrence deserve further investigation. The gene discussed is LY6E; the disease is pancreatic adenocarcinoma.